Copyright © 2013. All Rights Reserved.
9210 Corporate Boulevard, Suite 470, Rockville, MD 20850
|Time:||07:30 AM 11:30 AM|
|Location:||J. Craig Venter Institute Auditorium
9704 Medical Center Drive
Rockville, MD 20850
Last year, a federal District Court in New York ruled in Association for Molecular Pathology et al. v. U.S. Patent and Trademark Office et al. that isolated human genes are not patentable subject matter. This case (commonly referred to as the Myriad case) is currently on appeal to the Federal Circuit and challenges the eligibility and enforceability of patents directed to isolated genes and their fragments; however, its reasoning could be extended to invalidate patents on other natural products, such as antibiotics and proteins.
Our panel will provide you with a range of industry and government perspectives on the Myriad case and other current legal issues associated with gene patents. Come hear from these experts:
|Contact:||Email: Mark Glazer
Phone: (240) 243-4045